Modulation of restricted class II T cell responses by peptides derived from self class II molecule

Area of Science:

• Immunology
• Molecular Biology

Background:

• Major histocompatibility complex (MHC) class II molecules present peptides to T cells, playing a crucial role in immune responses.
• Modulating T cell responses is a key strategy in treating autoimmune diseases and enhancing vaccine efficacy.

Purpose of the Study:

• To investigate the potential of using peptides derived from the MHC class II I-Ab molecule to modulate I-Ab-restricted T cell responses.
• To analyze the binding affinity and inhibitory efficacy of these MHC-derived peptides.

Main Methods:

• Six peptides from polymorphic regions of I-Ab were synthesized.
• Competitive binding assays were performed to assess peptide binding to I-Ab.
• Inhibition of I-Ab-specific T cell responses was evaluated when peptides were administered with antigen.

Main Results:

• Peptide PB1 (residues 75-91 of beta chain) exhibited high-affinity binding to I-Ab.
• Both PB1 and PB2 (residues 59-78 of beta chain) effectively inhibited I-Ab-restricted T cell responses when co-administered with antigen.
• PB2 demonstrated inhibitory activity despite weak I-Ab binding, suggesting an alternative mechanism.
• Administration of PB1 and PB2 induced specific T cell responses but did not increase reactivity to I-Ab.

Conclusions:

• MHC class II-derived peptides can be utilized to regulate T cell responses.
• These peptides offer a potential therapeutic strategy for immune modulation without the risk of inducing autoreactivity.